Brief: Onxeo Announces Treatment Of First Patient In DRIIV-1b

Valerio Therapeutics SA

06/05/2019 17:03

May 6 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO ANNOUNCES TREATMENT OF FIRST PATIENT IN DRIIV-1B, A
PHASE
1B CLINICAL TRIAL OF ASIDNA IN COMBINATION WITH CHEMOTHERAPY
    * INITIAL RESULTS ARE EXPECTED IN SECOND HALF OF 2019
    * DRIIV-1B IS DESIGNED TO ASSESS CLINICAL POTENTIAL OF
ASIDNA IN
COMBINATION WITH CARBOPLATIN AND WITH CARBOPLATIN PLUS
PACLITAXEL IN PATIENTS WITH SOLID TUMORS ELIGIBLE TO SUCH
TREATMENTS

Source text for Eikon:  ID:nBw31V8sKa 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))